Background Insight into the delivery of interventions is necessary to gain a better understanding of what caused an intervention to succeed or fail. The Cardiovascular medication non-Adherence Tailored Intervention (CATI) study failed to show effectiveness of a patient-tailored, pharmacist-led intervention programme on self-reported adherence to antihypertensive medication...
PurposeTo obtain insight into the feasibility of, and the patients’ perspective on, dried blood spot (DBS) self-sampling by patients with chronic myeloid leukemia (CML) using nilotinib.MethodsSixty-eight patients with CML using nilotinib participated in this multicenter observational study. Patients were asked to perform blood sampling by means of the DBS method at home just...
This comprehensive observational study aimed to gain insight into adherence to nilotinib and the effect of (non)adherence on exposure (Cmin) and treatment outcomes. Chronic myeloid leukemia (CML) patients using nilotinib were followed for 12 months. Adherence was measured by Medication Event Monitoring System (MEMS), pill count, and Medication Adherence Report Scale (MARS-5...
Background The management of multiple long-term medicines of patients with chronic diseases creates a burden for patients. However, limited research is performed on its impact on patients’ daily lives. Objective The aim of this study was to explore the impact of cardiovascular medication on different daily life aspects and to examine differences of these aspects between adherent...
Center, De Boelelaan 1117, 1081 HV, Amsterdam, The NetherlandsLonneke Timmers, Christel C. L. M. Boons & Jacqueline G. HugtenburgUniversity Centre of Nursing and Midwifery, Department of Public Health ... AuthorsSearch for Lonneke Timmers in:PubMed • Google Scholar Search for Christel C. L. M. Boons in:PubMed • Google Scholar Search for Mathieu Verbrugghe in:PubMed • Google Scholar Search for Bart J. F. van den
Search for Christel C. L. M. Boons in:PubMed • Google Scholar Search for Judith E. Bosmans in:PubMed • Google Scholar Search for Giel Nijpels in:PubMed • Google Scholar Search for Jacqueline G
PurposeErlotinib is an orally administered tyrosine kinase inhibitor used for treatment of non-small cell lung cancer. Understanding actual use of medication is essential for optimizing treatment conditions.MethodsIn this multicentre prospective observational study, patients starting erlotinib treatment were followed for 4 months. Adherence was assessed using a medication event...
